SIBO

Definition: Small intestinal bacterial overgrowth (SIBO) is when the small intestines are colonized by excessive aerobic and anaerobic microbes that are normally found in the colon


Background:

Several disorders predispose to SIBO through alteration of the gut mucosal defenses (see below)

Intestinal motility disorders and chronic pancreatitis account for 90% of cases


Clinical Manifestations:


Endoscopy/ Histology:


Diagnosis:


Results:

 
If baseline hydrogen is >20ppm, may suggest poor adherence to pre-testing protocols

Constipation may increase levels of breath methane

False positive results: Rapid delivery of the test substrate to the colon (eg, in patients with short bowel syndrome)

False-negative results: occur in 30 to 40 percent of patients due to low anaerobic organism counts

 

Studies suggest, the glucose breath test sensitivity is 20 to 93 percent and specificity is 45 to 86 percent. The lactulose breath test had a sensitivity of 17 to 68 percent and specificity of 44 to 86 percent. Studies had several limitations. Some studies have suggested that the lactulose breath test has a slightly higher sensitivity for diagnosing SIBO as compared with the glucose breath test, others have failed to demonstrate significant differences in test performance

 

Treatment: (treat underlying etiology, if identified)

Initial treatment: (multiple alternatives available)

SIBO = Rifaxamin 550mg q8hrs (3x daily) for 14 days

SIBO + IMO = Neomycin 500mg BID and Rifaxamin 550mg q8hrs (3x daily) for 14 days

Correct vitamin deficiency if present


Recurrence

40% will have recurrence or persistence of symptoms

 

If patient cannot tolerate abx or there is a failure to respond to abx, consider elemental diet


Additional studies looking at role of probiotics, statins, and Low FODMAP diet